Core Insights - The Oncology Institute, Inc. (TOI) is expanding its strategic partnership with Helios Clinical Research to enhance community oncology care through integrated clinical research [1][2] - The partnership aims to streamline study activation, accelerate enrollment, and reduce operational burdens, allowing TOI to scale its research infrastructure while maintaining a focus on patient care [2] - TOI serves over 1.8 million patients and employs over 120 clinicians across more than 70 clinic locations, emphasizing its commitment to value-based cancer care [3] Strategic Benefits of the Partnership - Patients will have increased access to advanced therapies through clinical trials supported by Helios' centralized operations [5] - Sponsors will benefit from improved trial performance due to streamlined startup processes and optimized patient matching [5] - The partnership aims to enhance equity in oncology research by enrolling diverse and underrepresented patient populations [5]